Overview
- 38 inspections across 36 sites are on record.
- 30 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-06-06.
At a glance
Inspections
38
Sites
36
Observations
30
Career since
Jun 2011
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Aziz I. Shaibani, M.D. | 6 Jun 2025 | Human Drugs | |
| BioEclipse Therapeutics, Inc. | 25 Mar 2025 | Biologics | On file |
| Kaiser Foundation Research Institute IRB #8 | 10 Sep 2024 | Human Drugs | On file |
| SFJ Pharmaceuticals, Inc. | 23 Aug 2024 | Human Drugs | |
| Bruce E. Silverstein, M.D. | 9 Aug 2024 | Medical Devices & Rad Health | On file |
Sites inspected
Aziz I. Shaibani, M.D.Houston, United States1 insp.
BioEclipse Therapeutics, Inc.Mountain View, United States1 insp.
Kaiser Foundation Research Institute IRB #8Oakland, United States1 insp.
SFJ Pharmaceuticals, Inc.Pleasanton, United States1 insp.
Bruce E. Silverstein, M.D.Redding, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Dustin R Abaonza4 shared
Thea C Grome3 shared
Kristin M Abaonza2 shared
Rebecca T Davis2 shared
Deborah K Richardson2 shared
Vidhi J Jani1 shared
Cynthia J Tsui1 shared
Scott N Lim1 shared
Linh Tu1 shared
Byungja E Marciante1 shared
Full investigator report
Get the verbatim findings behind Joan T Briones' 30 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site